UK markets closed

LH Jan 2023 90.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.00000.0000 (0.00%)
As of 02:05PM EDT. Market open.
Full screen
Previous close1.0000
Open5.5000
Bid0.0000
Ask2.4000
Strike90.00
Expiry date2023-01-20
Day's rangeN/A - N/A
Contract rangeN/A
VolumeN/A
Open interest2
  • Business Wire

    Labcorp First National Laboratory to Offer Monkeypox Test

    BURLINGTON, N.C., July 06, 2022--Labcorp (NYSE: LH), a leading global life sciences company, today announced it will begin testing for monkeypox using the U.S. Centers for Disease Control and Prevention’s (CDC) orthopoxvirus test, which detects all non-smallpox related orthopoxviruses, including monkeypox. This effort is part of the Administration’s commitment to quickly increase monkeypox testing access and capacity in every community during the ongoing outbreak.

  • Zacks

    LabCorp (LH) to Strengthen Laboratory Footprint in Japan

    LabCorp's (LH) Drug Development arm, in collaboration with BML, will open a 4,000-square meters lab facility in Kawagoe for global clinical trials.

  • Business Wire

    Labcorp Plans Laboratory Expansion in Japan Through BML Collaboration

    BURLINGTON, N.C., June 28, 2022--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it is enhancing its central laboratory presence and drug development capabilities in Japan through an expansion of CB Trial Laboratory, the central laboratory co-managed by Labcorp Drug Development and BML, a leading Japanese provider of clinical laboratory testing services.